Get access to our best features
Get Started
Subscribe
Israel-Hamas Conflict
Tornado
US Politics
Baseball
NFL
2024 US Election
Donald Trump
Joe Biden
Republican Party
US Economy
US Social Issues
David Pecker
Columbia University
Get access to our best features
Get Started
Published 1 month ago

Medicare spending on Ozempic and similar diabetes drugs soars. It could end up costing seniors

Summary by Ground News
Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis. The pricey medications, which include Mounjaro and Rybelsus, have become super popular for the treatment of diabetes and for weight loss. Medicare recently announced that it would cover Wegovy in people who are obese or overweight and have heart disease after the drug gained approval for cardiovascular benefits.

0 Articles

All
Left
Center
Right
KCRA 3KCRA 3

Medicare spending on Ozempic and similar diabetes drugs soars. It could end up costing seniors

Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis.

1 month ago·Sacramento, United States
Read Full Article
WCVBWCVB

Medicare spending on Ozempic and similar diabetes drugs soars. It could end up costing seniors

Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis.

1 month ago·Boston, United States
Read Full Article
WLWTWLWT

Medicare spending on Ozempic and similar diabetes drugs soars. It could end up costing seniors

Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis.

1 month ago·Cincinnati, United States
Read Full Article
WMURWMUR

Medicare spending on Ozempic and similar diabetes drugs soars. It could end up costing seniors

Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis.

1 month ago
Read Full Article
WLKYWLKY

Medicare spending on Ozempic and similar diabetes drugs soars. It could end up costing seniors

Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis.

1 month ago·Louisville, United States
Read Full Article
WESHWESH

Medicare spending on Ozempic and similar diabetes drugs soars. It could end up costing seniors

Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis.

1 month ago
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

MedicareMedicare
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal